A common feature of general anaesthetic agents is their ability to pot
entiate neuronal inhibition through GABA(A) (gamma-aminobutyric acid)
receptors(1). At concentrations relevant to clinical anaesthesia, thes
e agents cause a dramatic stimulation of the chloride currents that ar
e evoked by the binding of the natural ligand, GABA. Although there is
widespread evidence that the sensitivity of GABA(A) receptors to anae
sthetic agents is heterogeneous(2-4), the structural basis of these di
fferences is largely unknown. Variations in subunit composition can ha
ve profound effects on the sensitivity of GABA(A), receptors to modula
tory agents such as benzodiazepines(5). However, strict subunit specif
icity has not been demonstrated for the potentiating effects of anaest
hetic agents(6-10). Here we describe a new class of human GABA(A) rece
ptor subunit (epsilon) that can assemble with alpha- and beta-subunits
and confer an insensitivity to the potentiating effects of intravenou
s anaesthetic agents. The epsilon-subunit also abolishes the normal ou
tward rectification of recombinant receptors in which it assembles. Th
e expression pattern of this subunit in the brain suggests a new targe
t for manipulation of neuronal pathways within the basal ganglia.